ARCHIVES

DCE Board Approves Concepts For New Chemoprevention Groups, Retroviral Vaccine Research, Biochemical Markers, Feline Virus Studies

This article is from The Cancer Letter archive.

Vol. 11 No. 11 | March 15, 1985

Download PDF Visit The Full Archive

Related Articles

Grassley Pledges More Congressional Oversight of CME.

March 14, 2008

In Brief: Harold Moses Directs Vanderbilt Cancer Center; Carl Fretts, NIH contracts Director, To Retire

June 11, 1993

Adjuvant XELOX More Effective Than 5-FU/LV For Stage III Colon Cancer

January 29, 2010

Other DCE Contract Recompetitions OKed

November 15, 1985

NCI Cooperative Group, Cancer Center Trials Listed

September 26, 2008

In Brief: Terry To Leave NCI for Job As VP Of Revlon Health Care Group; NCI Tracking Source Of Breakthroughs

June 18, 1982